AP NEWS

Cognition & Memory Enhancement Drugs: Technologies and Global Markets to 2022 - ResearchAndMarkets.com

July 11, 2018

DUBLIN--(BUSINESS WIRE)--Jul 11, 2018--The “Cognition and Memory Enhancement Drugs: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering.

This research report presents an in-depth analysis of the global cognition and memory-enhancing drugs market by application, product categories, and regional markets. The report includes key cognition drugs that are incorporated in several therapeutic treatment methods. It discusses the role of supply chain members from manufacturers to researchers.

The report has an in-depth analysis of key companies operating in the global cognition and memory-enhancing drugs market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and regions such as the U.S., Europe, and China.

The cognition and memory-enhancing drugs market is segmented mainly into eight components: Aricept, Exelon, Reminyl, Namenda, Adderall, Ritalin, Dexedrin, and other cognition drugs. This market is further segmented on the basis of applications, which helps in understanding the potency of these memory enhancers in several therapeutic treatments.

The market study is detailed for products based on applications as well as its further implication on the research and development area. These two segmentations are also discussed in detail for the given period. The market is segmented by region into the North America, Europe, Asia-Pacific, and ROW.

Report Scope

An overview of the global market for cognition and memory enhancement drugs Analyses of global market trends, with data from 2016 to 2017, and projections of compound annual growth rates (CAGRs) through 2022 An overview of the ethics and side effects of cognition and memory enhancement drugs Market analyses by application, product, and region Assessment of patent litigation claims Insight into the competitive landscape, including mergers and acquisitions and new product launches Profiles of key companies in the market, including Pfizer, Novartis, Shire Pharmaceuticals, Allergan Plc, Barr Pharmaceuticals, and Cephalon

Companies Featured

Accelerated Intelligence Inc. Allergan Plc Alternascript Llc Cambridge Cognition Ceretropic Cognition Therapeutics Inc. Cogstate Ltd. HVMN Nootriment Novartis Ag Onnit Labs Llc Peak Nootropics Pfizer Inc. Purelife Bioscience Co., Ltd. Shire Supnootropic Bio Co., Ltd. Teva Pharmaceuticals Industries Ltd. (Barr Pharmaceuticals)

Key Topics Covered

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Chapter 4 Global Cognition and Memory-Enhancing Drugs Market Breakdown by Product Type

Chapter 5 Global Cognition and Memory-Enhancing Drugs Market Breakdown by Application

Chapter 6 Global Cognition and Memory-Enhancing Drugs Market Breakdown by Region

Chapter 7 Patent Review

Chapter 8 Analysis of Market Opportunities

Chapter 9 Company Profiles

Chapter 10 Appendix: Patents, Drugs and Cognitive Enhancers

For more information about this report visit https://www.researchandmarkets.com/research/vfskvq/cognition_and?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180711005428/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/11/2018 08:03 AM/DISC: 07/11/2018 08:03 AM

http://www.businesswire.com/news/home/20180711005428/en

AP RADIO
Update hourly